224 related articles for article (PubMed ID: 26470032)
21. Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.
Balagopal A; Asmuth DM; Yang WT; Campbell TB; Gupte N; Smeaton L; Kanyama C; Grinsztejn B; Santos B; Supparatpinyo K; Badal-Faesen S; Lama JR; Lalloo UG; Zulu F; Pawar JS; Riviere C; Kumarasamy N; Hakim J; Li XD; Pollard RB; Semba RD; Thomas DL; Bollinger RC; Gupta A;
J Acquir Immune Defic Syndr; 2015 Oct; 70(2):163-71. PubMed ID: 26017661
[TBL] [Abstract][Full Text] [Related]
22. Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
Stiksrud B; Aass HCD; Lorvik KB; Ueland T; Trøseid M; Dyrhol-Riise AM
AIDS; 2019 Jun; 33(7):1117-1129. PubMed ID: 30789356
[TBL] [Abstract][Full Text] [Related]
23. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
24. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.
Piconi S; Parisotto S; Rizzardini G; Passerini S; Terzi R; Argenteri B; Meraviglia P; Capetti A; Biasin M; Trabattoni D; Clerici M
Blood; 2011 Sep; 118(12):3263-72. PubMed ID: 21576701
[TBL] [Abstract][Full Text] [Related]
25. Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients.
Merlini E; Cerrone M; van Wilgenburg B; Swadling L; Cannizzo ES; d'Arminio Monforte A; Klenerman P; Marchetti G
Front Microbiol; 2019; 10():1972. PubMed ID: 31555223
[TBL] [Abstract][Full Text] [Related]
26. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
[TBL] [Abstract][Full Text] [Related]
27. Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients.
Xia P; Xing XD; Yang CX; Liao XJ; Liu FH; Huang HH; Zhang C; Song JW; Jiao YM; Shi M; Jiang TJ; Zhou CB; Wang XC; He Q; Zeng QL; Wang FS; Zhang JY
Mil Med Res; 2022 May; 9(1):24. PubMed ID: 35619176
[TBL] [Abstract][Full Text] [Related]
28. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
[TBL] [Abstract][Full Text] [Related]
29. A Low Frequency of IL-17-Producing CD8
Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
Front Immunol; 2018; 9():2502. PubMed ID: 30420859
[TBL] [Abstract][Full Text] [Related]
30. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
[TBL] [Abstract][Full Text] [Related]
31. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
Neurauter G; Zangerle R; Widner B; Quirchmair G; Sarcletti M; Fuchs D
Adv Exp Med Biol; 2003; 527():317-23. PubMed ID: 15206745
[TBL] [Abstract][Full Text] [Related]
32. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution.
Yap SH; Abdullah NK; McStea M; Takayama K; Chong ML; Crisci E; Larsson M; Azwa I; Kamarulzaman A; Leong KH; Woo YL; Rajasuriar R
PLoS One; 2017; 12(10):e0186000. PubMed ID: 29016635
[TBL] [Abstract][Full Text] [Related]
33. Increased frequencies of Th17 cells and IL17a-producing regulatory T-cells preceding the immunodiscordant response to antiretroviral treatment.
Rosado-Sánchez I; Herrero-Fernández I; Tarancon-Diez L; Moreno S; Iribarren JA; Dalmau D; Vera-Méndez F; Leal M; Pacheco YM
J Infect; 2018 Jan; 76(1):86-92. PubMed ID: 29079322
[TBL] [Abstract][Full Text] [Related]
34. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
35. Addition of maraviroc to antiretroviral therapy decreased interferon-γ mRNA in the CD4+ T cells of patients with suboptimal CD4+ T-cell recovery.
Minami R; Takahama S; Kaku Y; Yamamoto M
J Infect Chemother; 2017 Jan; 23(1):29-34. PubMed ID: 27729193
[TBL] [Abstract][Full Text] [Related]
36. Attrition of TCR Vα7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression.
Saeidi A; Tien Tien VL; Al-Batran R; Al-Darraji HA; Tan HY; Yong YK; Ponnampalavanar S; Barathan M; Rukumani DV; Ansari AW; Velu V; Kamarulzaman A; Larsson M; Shankar EM
PLoS One; 2015; 10(4):e0124659. PubMed ID: 25894562
[TBL] [Abstract][Full Text] [Related]
37. Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.
Jenabian MA; Patel M; Kema I; Vyboh K; Kanagaratham C; Radzioch D; Thébault P; Lapointe R; Gilmore N; Ancuta P; Tremblay C; Routy JP
Clin Exp Immunol; 2014 Oct; 178(1):102-11. PubMed ID: 24924152
[TBL] [Abstract][Full Text] [Related]
38. Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4
Tasca KI; Correa CR; Caleffi JT; Mendes MB; Gatto M; Manfio VM; de Camargo CC; Tavares FC; Biasin M; de Souza LDR
J Immunol Res; 2018; 2018():7531718. PubMed ID: 29992171
[TBL] [Abstract][Full Text] [Related]
39. Immunoregulatory T cells may be involved in preserving CD4 T cell counts in HIV-infected long-term nonprogressors and controllers.
Gaardbo JC; Ronit A; Hartling HJ; Gjerdrum LM; Springborg K; Ralfkiær E; Thorsteinsson K; Ullum H; Andersen ÅB; Nielsen SD
J Acquir Immune Defic Syndr; 2014 Jan; 65(1):10-8. PubMed ID: 23995946
[TBL] [Abstract][Full Text] [Related]
40. Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults.
Mathiesen IH; Salem M; Gerstoft J; Gaardbo JC; Obel N; Pedersen C; Ullum H; Nielsen SD; Hansen AE
BMC Infect Dis; 2017 Apr; 17(1):262. PubMed ID: 28399815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
